Nocion Therapeutics, Inc. Email Format

Biotechnology ResearchMassachusetts, United States11-50 Employees

Nocion Therapeutics is a clinical‑stage biotechnology company based in Watertown, Massachusetts, focused on conditions driven by overactive sensory nerves, including chronic cough, itch, and pain. It is developing a platform of targeted molecules that act directly on inflamed nociceptors to dampen abnormal nerve signals at their source, with the aim of delivering longer‑lasting relief while preserving normal sensation. The lead program, tapuclainium as a dry powder for inhalation, is being pursued for adults with refractory or unexplained chronic cough, a condition that can persist for months or years and affects about nine million adults in the United States. 

The company describes its niche as addressing underserved conditions by providing targeted relief that can enable people to resume daily activities. Nocion positions itself within the biotechnology research sector by pursuing a mechanism that targets actively firing nociceptors, differentiating its approach from broader analgesic strategies. In May 2026, the company appointed Vineet Agarwal as Chief Business Officer, reflecting ongoing leadership development as it advances its clinical programs.

Get verified Nocion Therapeutics, Inc. emails free

Company overview Employee directory